These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29707855)

  • 1. Random forests of interaction trees for estimating individualized treatment effects in randomized trials.
    Su X; Peña AT; Liu L; Levine RA
    Stat Med; 2018 Jul; 37(17):2547-2560. PubMed ID: 29707855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case-only trees and random forests for exploring genotype-specific treatment effects in randomized clinical trials with dichotomous endpoints.
    Dai JY; LeBlanc M
    J R Stat Soc Ser C Appl Stat; 2019 Nov; 68(5):1371-1391. PubMed ID: 32489221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating individual treatment effects by gradient boosting trees.
    Sugasawa S; Noma H
    Stat Med; 2019 Nov; 38(26):5146-5159. PubMed ID: 31460679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk controlled decision trees and random forests for precision Medicine.
    Doubleday K; Zhou J; Zhou H; Fu H
    Stat Med; 2022 Feb; 41(4):719-735. PubMed ID: 34786731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating individualized treatment effects using an individual participant data meta-analysis.
    Bouvier F; Chaimani A; Peyrot E; Gueyffier F; Grenet G; Porcher R
    BMC Med Res Methodol; 2024 Mar; 24(1):74. PubMed ID: 38528447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonparametric machine learning for precision medicine with longitudinal clinical trials and Bayesian additive regression trees with mixed models.
    Spanbauer C; Sparapani R
    Stat Med; 2021 May; 40(11):2665-2691. PubMed ID: 33751659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model selection for survival individualized treatment rules using the jackknife estimator.
    Honvoh GD; Cho H; Kosorok MR
    BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of predicted individual treatment effects in randomized clinical trials.
    Lamont A; Lyons MD; Jaki T; Stuart E; Feaster DJ; Tharmaratnam K; Oberski D; Ishwaran H; Wilson DK; Van Horn ML
    Stat Methods Med Res; 2018 Jan; 27(1):142-157. PubMed ID: 26988928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Simulation-Based Comparison of Covariate Adjustment Methods for the Analysis of Randomized Controlled Trials.
    Chaussé P; Liu J; Luta G
    Int J Environ Res Public Health; 2016 Apr; 13(4):414. PubMed ID: 27077870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refined moderation analysis with binary outcomes in precision medicine research.
    Anto E; Su X
    Stat Methods Med Res; 2023 Apr; 32(4):732-747. PubMed ID: 36721908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confidence Intervals for Random Forests: The Jackknife and the Infinitesimal Jackknife.
    Wager S; Hastie T; Efron B
    J Mach Learn Res; 2014 Jan; 15(1):1625-1651. PubMed ID: 25580094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imputation strategies for missing binary outcomes in cluster randomized trials.
    Ma J; Akhtar-Danesh N; Dolovich L; Thabane L;
    BMC Med Res Methodol; 2011 Feb; 11():18. PubMed ID: 21324148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Risk Prediction in Clinical Oncology Research: Applications and Practical Issues Using Survival Trees and Random Forests.
    Hu C; Steingrimsson JA
    J Biopharm Stat; 2018; 28(2):333-349. PubMed ID: 29048993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of the optimal personalized treatment from multiple treatments with multivariate outcome measures.
    Siriwardhana C; Datta S; Kulasekera KB
    J Biopharm Stat; 2020 May; 30(3):462-480. PubMed ID: 31691633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using audit information to adjust parameter estimates for data errors in clinical trials.
    Shepherd BE; Shaw PA; Dodd LE
    Clin Trials; 2012 Dec; 9(6):721-9. PubMed ID: 22848072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical Guide to Honest Causal Forests for Identifying Heterogeneous Treatment Effects.
    Jawadekar N; Kezios K; Odden MC; Stingone JA; Calonico S; Rudolph K; Zeki Al Hazzouri A
    Am J Epidemiol; 2023 Jul; 192(7):1155-1165. PubMed ID: 36843042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covariate adjustment in randomized clinical trials with missing covariate and outcome data.
    Chang CR; Song Y; Li F; Wang R
    Stat Med; 2023 Sep; 42(22):3919-3935. PubMed ID: 37394874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting treatment-covariate interactions using permutation methods.
    Wang R; Schoenfeld DA; Hoeppner B; Evins AE
    Stat Med; 2015 May; 34(12):2035-47. PubMed ID: 25736915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.